Delek Group Ltd.
Delek Group Ltd. (DLKGF) Financial Performance & Income Statement Overview
Analyze Delek Group Ltd. (DLKGF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Delek Group Ltd. (DLKGF) Income Statement & Financial Overview
View the income breakdown for Delek Group Ltd. DLKGF across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.85B | $3.89B | $2.59B | $2.52B |
| Cost of Revenue | $1.56B | $1.67B | $1.50B | $1.48B |
| Gross Profit | $2.29B | $2.22B | $1.10B | $1.04B |
| Gross Profit Ratio | $0.59 | $0.57 | $0.42 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $70.00M | -$14.00M | $61.00M | $86.00M |
| Operating Expenses | $44.00M | $726.00M | $355.00M | $208.00M |
| Total Costs & Expenses | $1.60B | $2.40B | $1.85B | $1.69B |
| Interest Income | $82.00M | -$478.00M | $281.00M | $241.00M |
| Interest Expense | $501.00M | $42.00M | $350.00M | $388.00M |
| Depreciation & Amortization | $927.00M | $1.61B | $851.00M | $640.00M |
| EBITDA | $3.25B | $2.76B | $1.87B | $1.46B |
| EBITDA Ratio | $0.85 | $0.71 | $0.72 | $0.58 |
| Operating Income | $2.25B | $1.49B | $741.00M | $831.00M |
| Operating Income Ratio | $0.58 | $0.38 | $0.29 | $0.33 |
| Other Income/Expenses (Net) | -$419.00M | -$383.00M | -$69.00M | -$147.00M |
| Income Before Tax | $1.83B | $1.11B | $672.00M | $684.00M |
| Income Before Tax Ratio | $0.47 | $0.29 | $0.26 | $0.27 |
| Income Tax Expense | $1.77B | $476.00M | $31.00M | $123.00M |
| Net Income | $10.00M | $350.00M | $403.00M | $382.00M |
| Net Income Ratio | $0.003 | $0.09 | $0.16 | $0.15 |
| EPS | $0.50 | $19.05 | $21.80 | $20.50 |
| Diluted EPS | $0.50 | $19.05 | $21.80 | $20.50 |
| Weighted Avg Shares Outstanding | $20.00M | $18.47M | $18.49M | $18.63M |
| Weighted Avg Shares Outstanding (Diluted) | $20.00M | $18.48M | $18.49M | $18.63M |
The company's financials show resilient growth, with revenue advancing from $2.52B in Q2 2024 to $3.85B in Q1 2025. Gross profit remained healthy with margins at 59% in Q1 2025 compared to 41% in Q2 2024. Operating income hit $2.25B last quarter, sustaining a consistent 58% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $3.25B. Net income dropped to $10.00M, while earnings per share reached $0.50. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan